Welcome to LookChem.com Sign In|Join Free

CAS

  • or

71031-02-2

Post Buying Request

71031-02-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71031-02-2 Usage

Description

(R)-2-Oxiranylanisole is a chiral organic compound characterized by the presence of an oxirane (epoxide) ring and an anisole (methoxyphenol) group. It exhibits a specific stereochemistry, with the R-configuration, which is crucial for its reactivity and applications in various chemical and pharmaceutical processes.

Uses

Used in Pharmaceutical Industry:
(R)-2-Oxiranylanisole is used as a key intermediate in the synthesis of neuroprotective small molecules and piperidinol analogs. These compounds are essential for the development of drugs targeting neurological disorders and diseases.
Used in Chemical Research:
(R)-2-Oxiranylanisole is used as a reactant in the synthesis of various chemical compounds, such as 2-substituted 3,4-dihydro-2H-1,4-benzoxazines, bicyclic azetidines, and bromoalkanes. Its unique structure allows for cyclization, ring-opening, esterification, chlorination, and intramolecular alkylation reactions, making it a versatile building block in organic chemistry.
Used in Biological Studies:
(R)-2-Oxiranylanisole is utilized as a substrate in biological studies involving Bacillus-produced enantioselective epoxide hydrolase. This enzyme plays a crucial role in the breakdown of epoxides, which are important in understanding metabolic pathways and detoxification processes in microorganisms.
Used in Anti-tuberculosis Research:
(R)-2-Oxiranylanisole is employed as a reactant in the synthesis of compounds for studies of anti-tuberculosis activity. Its unique properties make it a valuable component in the development of new drugs to combat tuberculosis, a significant global health concern.

Check Digit Verification of cas no

The CAS Registry Mumber 71031-02-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,0,3 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 71031-02:
(7*7)+(6*1)+(5*0)+(4*3)+(3*1)+(2*0)+(1*2)=72
72 % 10 = 2
So 71031-02-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O2/c1-10-8-5-3-2-4-7(8)9-6-11-9/h2-5,9H,6H2,1H3/t9-/m0/s1

71031-02-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0409)  (R)-Glycidyl Phenyl Ether  >95.0%(GC)

  • 71031-02-2

  • 1g

  • 1,280.00CNY

  • Detail
  • Aldrich

  • (29438)  (R)-2-Oxiranylanisole  ≥97.0% (sum of enantiomers, GC)

  • 71031-02-2

  • 29438-1G-F

  • 5,825.43CNY

  • Detail

71031-02-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-2-(Phenoxymethyl)oxirane

1.2 Other means of identification

Product number -
Other names (R)-2-Oxiranylanisole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71031-02-2 SDS

71031-02-2Relevant articles and documents

PRACTICAL PREPARATION OF OPTICALLY ACTIVE O-BENZYLGLYCIDOL FROM OPTICALLY ACTIVE EPICHLOROHYDRIN

Takano, Seiichi,Sekiguchi, Yoshinori,Setoh, Masaki,Yoshimitsu, Takehiko,Inomata, Kohei,et al.

, p. 1715 - 1719 (1990)

Practical preparation of optically active O-benzylglycidol has been developed starting from optically active epichlorohydrin by employing either basic or acidic conditions in the key stage.

Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design

álvarez, Diego E.,Battini, Leandro,Bollini, Mariela,Fidalgo, Daniela M.

, p. 1503 - 1518 (2021/06/28)

The worldwide expansion of chikungunya virus (CHIKV) into tropical and subtropical areas in the last 15 years has posed a currently unmet need for vaccines and therapeutics. The E2-E1 envelope glycoprotein complex binds receptors on the host cell and promotes membrane fusion during CHIKV entry, thus constituting an attractive target for the development of antiviral drugs. In order to identify CHIKV antivirals acting through inhibition of the envelope glycoprotein complex function, our first approach was to search for amenable druggable sites within the E2-E1 heterodimer. We identified a pocket located in the interface between E2 and E1 around the fusion loop. Then, via a structure-based virtual screening approach and in vitro assay of antiviral activity, we identified compound 7 as a specific inhibitor of CHIKV. Through a lead optimization process, we obtained compound 11 that demonstrated increased antiviral activity and low cytotoxicity (EC50 1.6 μM, CC50 56.0 μM). Molecular dynamics simulations were carried out and described a possible interaction pattern of compound 11 and the E1-E2 dimer that could be useful for further optimization. As expected from target site selection, compound 11 inhibited virus internalization during CHIKV entry. In addition, virus populations resistant to compound 11 included mutation E2-P173S, which mapped to the proposed binding pocket, and second site mutation E1-Y24H. Construction of recombinant viruses showed that these mutations conferred antiviral resistance in the parental background. Finally, compound 11 presents acceptable solubility values and is chemically and enzymatically stable in different media. Altogether, these findings uncover a suitable pocket for the design of CHIKV entry inhibitors with promising antiviral activity and pharmacological profiles.

An Amphiphilic (salen)Co Complex – Utilizing Hydrophobic Interactions to Enhance the Efficiency of a Cooperative Catalyst

Solís-Mu?ana, Pablo,Salam, Joanne,Ren, Chloe Z.-J.,Carr, Bronte,Whitten, Andrew E.,Warr, Gregory G.,Chen, Jack L.-Y.

supporting information, p. 3207 - 3213 (2021/06/01)

An amphiphilic (salen)Co(III) complex is presented that accelerates the hydrolytic kinetic resolution (HKR) of epoxides almost 10 times faster than catalysts from commercially available sources. This was achieved by introducing hydrophobic chains that increase the rate of reaction in one of two ways – by enhancing cooperativity under homogeneous conditions, and increasing the interfacial area under biphasic reaction conditions. While numerous strategies have been employed to increase the efficiency of cooperative catalysts, the utilization of hydrophobic interactions is scarce. With the recent upsurge in green chemistry methods that conduct reactions ‘on water’ and at the oil-water interface, the introduction of hydrophobic interactions has potential to become a general strategy for enhancing the catalytic efficiency of cooperative catalytic systems. (Figure presented.).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71031-02-2